Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Earlier roles on record: Board Member at Angiodynamics Inc (ANGO) until November 2, 2026. Angiodynamics Inc reported in an 8-K filed October 8, 2026 that James C. Clemmer retired as member of the Board, effective November 2, 2026. Angiodynamics Inc reported in an 8-K filed October 8, 2026 that James C. Clemmer retired as President and Chief Executive Officer, effective November 2, 2026. Angiodynamics Inc reported in an 8-K filed February 3, 2026 that James C. Clemmer retired as President and Chief Executive Officer, effective November 30, 2026. Equibles holds 4 filed executive changes naming James C. Clemmer; each is listed under recent activity with its source filing. The proxy statement of Angiodynamics Inc reports total compensation of $6,060,145 for James C. Clemmer in fiscal 2026, including a base salary of $828,171. Disclosed compensation is on record for 9 fiscal years. James C. Clemmer has spoken on 1 investor event across 1 company, most recently for Angiodynamics Inc on June 10, 2026.
“In addition, Mr. Honroth was appointed as a director on the Company’s Board as of the Effective Date, conditioned upon his commencement of service as President and Chief Executive Officer and concurrently with Mr. Clemmer’s retirement from his position as a member of the Board.”
“As previously disclosed, James C. Clemmer has announced his intention to retire from his position as the President and Chief Executive Officer of the Company on the earlier of November 30, 2026 and appointment of a successor Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-11-14–2026-11-02
Recorded roles and call appearances connecting this person to public companies.
ANGO
Board Member
2023-11-14–2026-11-02
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Angiodynamics Inc (ANGO) | President, CEO | $828,171 | $6,060,145 |
| 2025 | Angiodynamics Inc (ANGO) | President, CEO | $803,027 | $5,494,285 |
| 2024 | Angiodynamics Inc (ANGO) | President, CEO | $783,000 | $5,005,971 |
| 2023 | Angiodynamics Inc (ANGO) | President, CEO | $756,154 | $3,983,691 |
| 2022 | Angiodynamics Inc (ANGO) | President, CEO | $736,154 | $5,659,728 |
| 2021 | Angiodynamics Inc (ANGO) | President, CEO | $720,000 | $4,045,913 |
| 2020 | Angiodynamics Inc (ANGO) | President, CEO | $716,164 | $3,116,631 |
| 2019 | Angiodynamics Inc (ANGO) | President, CEO | $686,575 | $3,001,490 |
| 2018 | Angiodynamics Inc (ANGO) | President, CEO | $643,269 | $2,742,621 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
